Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women.
Diego Moretti, Jeroen S Goede, Christophe Zeder...
https://pubmed.ncbi.nlm.nih.gov/26289639/Actively Recruiting
Led by Istanbul University - Cerrahpasa · Updated on 2025-12-04
60
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are studying women aged 18 to 55 years who have non-anemic iron deficiency to understand the risk of developing anemia and to evaluate the effects of oral iron therapy. The study aims to identify early signs that predict anemia progression and to assess how dietary changes and iron treatment impact symptoms and blood test results. This research focuses on individual factors related to iron deficiency and its management. Participants first undergo a two-month nutritional intervention where they receive counseling to increase iron intake and absorption through diet. After this phase, blood tests categorize participants into groups based on their iron status. Those with persistent iron deficiency then receive a daily oral dose of 80 mg elemental iron ferrous sulfate for one month. Adherence and symptoms are monitored regularly by phone and clinic visits throughout both phases. During the study, participants complete symptom questionnaires and have blood tests to measure hemoglobin, ferritin, iron levels, and inflammatory markers at the start, after the nutritional phase, and following the iron therapy. Researchers track changes in symptoms and laboratory values to evaluate the effects of the interventions. The total study period includes two months of diet counseling and one month of oral iron treatment, with ongoing monitoring to assess safety and response.
CONDITIONS
Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years)
O
Osman Demir, MD
A
Ayşen Fenercioğlu, Assoc Prof
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istanbul University - Cerrahpasa
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 months
Participants receive a two-month nutritional counseling program to increase iron intake and improve absorption, with biweekly phone follow-ups to monitor adherence and symptoms.
Biweekly phone follow-ups
Duration - 1 month
Participants with persistent iron deficiency after the nutritional intervention receive one-month oral iron therapy with 80 mg elemental iron daily, including biweekly phone follow-ups and adherence monitoring.
Biweekly phone follow-ups
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Diego Moretti, Jeroen S Goede, Christophe Zeder...
https://pubmed.ncbi.nlm.nih.gov/26289639/O Ortancil, A Sanli, R Eryuksel...
https://pubmed.ncbi.nlm.nih.gov/20087382/Andrew Fletcher, Adam Forbes, Nicola Svenson...
https://pubmed.ncbi.nlm.nih.gov/34693519/Shalini Balendran, Cecily Forsyth
https://pubmed.ncbi.nlm.nih.gov/35002031/Esa T Soppi
https://pubmed.ncbi.nlm.nih.gov/29881569/Takako Sawada, Aki Konomi, Katsuhiko Yokoi
https://pubmed.ncbi.nlm.nih.gov/24756645/Lachlan F Miles, Edward Litton, Georgina Imberger...
https://pubmed.ncbi.nlm.nih.gov/31860749/Xiao-Ying Zhu, Ting-Ting Wu, Hong-Ming Wang...
https://pubmed.ncbi.nlm.nih.gov/32425874/Dominika Skolmowska, Dominika Głąbska, Aleksandra Kołota...
https://pubmed.ncbi.nlm.nih.gov/35807904/Matthew W Stefan, David M Gundermann, Matthew H Sharp...
https://pubmed.ncbi.nlm.nih.gov/37299583/Istanbul University - Cerrahpasa
Lead Sponsor